Cover Image
市場調查報告書

神經退化疾病診斷突破

Diagnostic Breakthroughs for Neurodegenerative Diseases

出版商 Technical Insights (Frost & Sullivan) 商品編碼 355846
出版日期 內容資訊 英文 64 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
神經退化疾病診斷突破 Diagnostic Breakthroughs for Neurodegenerative Diseases
出版日期: 2016年03月30日 內容資訊: 英文 64 Pages
簡介

本報告提供神經退化疾病診斷中,預計在不久的將來會帶來大幅影響的主要的技術趨勢、發展的相關調查,各技術 (神經生物標記、神經成像,及神經資訊學) 概要,神經診斷市場上新創新,神經診斷技術的促進要素、課題,市場引進,合作,資金及專利情形等相關分析。

第1章 摘要整理

第2章 R&D組合分析

  • 神經退化性疾病概要
  • 神經退化疾病診斷 - 區分
  • 生物標記為基礎的診斷:概要
  • 適合神經診斷的主要生物標記
  • 神經學中新的生物標記診斷
  • 神經成像技術:概要
  • 神經成像技術:創新的生態系統
  • 神經資訊學:概要
  • 神經資訊學:創新的生態系統

第3章 資金分析

  • 對神經生物標記的風險企業投資情形
  • 對神經生物標記計劃的公共資金形勢

第4章 環境分析

  • 主要的技術促進要素、課題
  • 主要的技術促進要素
  • 主要的技術課題
  • 主要的推動市場的要素、課題
  • 主要的推動市場的要素
  • 主要市場課題
  • 臨床實驗分析
  • 生物標記診斷的引進情形
  • 神經成像技術的引進情形
  • 神經信息學工具的引進情形

第5章 策略性考察

  • 合作情形概要
  • 產品開發聯盟:診斷
  • 產品開發聯盟:搭配診斷
  • 授權、研究合作
  • 調查國際集團
  • 新技術
  • 結論

第6章 專利分析

第7章 主要契約、附錄

第8章 關於Frost&Sullivan

目錄
Product Code: D6BC-01-00-00-00

R&D Portfolio Analysis of Neurodiagnostic Innovations

This research service covers key technological trends and developments in diagnostics for neurodegenerative diseases, which are likely to have a high impact in the near future. The technologies present across the global neurodiagnostic industry have been covered under neurobiomarkers, neuroimaging and neuroinformatics segments. While providing brief overviews for each technology, the research service also covers industrial snapshots and emerging innovations in the neurodiagnostic markets. The research service also includes drivers & challenges, market adoption, collaborations, funding and patent scenarios for neurodiagnostic technologies.

Table of Contents

1. EXECUTIVE SUMMARY

  • 1. Scope of Research
  • 2. Research Methodology
  • 3. Research Methodology (continued)
  • 4. Key Findings

2. R&D PORTFOLIO ANALYSIS

  • 1. Overview of Neurodegenerative Diseases
  • 2. Neurodegenerative Disease Diagnostics-Segmentation
  • 3. Biomarker-based Diagnostics: Overview
  • 4. Key Biomarkers for Neurodiagnostics
  • 5. Emerging Biomarker Diagnostics in Neurology (1/2)
  • 6. Emerging Biomarker Diagnostics in Neurology (2/2)
  • 7. Neuroimaging Technologies: Overview
  • 8. Neuroimaging Technologies
  • 9. Neuroimaging Technologies
  • 10. Neuroimaging Technologies
  • 11. Neuroimaging Technologies: Innovation Ecosystems
  • 12. Neuroinformatics: Overview
  • 13. Neuroinformatics: Innovation Ecosystems

3. FUNDING ANALYSIS

  • 1. Venture Investment Scenario for Neurobiomarkers
  • 2. Public Funding Landscape for Neurobiomarker Projects
  • 3. Public Funding Landscape for Neurobiomarker Projects (continued)

4. ENVIRONMENTAL ANALYSIS

  • 1. Key Technological Drivers and Challenges
  • 2. Key Technological Drivers
  • 3. Key Technological Challenges
  • 4. Key Market Drivers and Challenges
  • 5. Key Market Drivers
  • 6. Key Market Challenges
  • 7. Clinical Trials Analysis
  • 8. Adoption Scenario for Biomarker Diagnostics
  • 9. Adoption Scenario for Neuroimaging Techniques
  • 10. Adoption Scenario for Neuroinformatic Tools

5. STRATEGIC INSIGHTS

  • 1. Overview of the Collaborative Landscape
  • 2. Product Development Partnerships-Diagnostics
  • 3. Product Development Partnerships-Companion Diagnostics
  • 4. Licensing and Research Collaborations
  • 5. Research Consortia
  • 6. Emerging Technologies
  • 7. Conclusions

6. PATENT ANALYSIS

  • 1. Patent Search Scope
  • 2. Patents for Neurodegenerative Diseases-Timeline Overview
  • 3. Global Patent Spread by Assignees
  • 4. Global Patent Spread by Patent Offices

7. KEY CONTACTS AND APPENDIX

  • 1. Key Contacts
  • 2. Appendix I
  • 3. Appendix I
  • 4. Appendix II

8. THE FROST & SULLIVAN STORY

  • 1. The Frost & Sullivan Story
  • 2. Value Proposition: Future of Your Company & Career
  • 3. Global Perspective
  • 4. Industry Convergence
  • 5. 360° Research Perspective
  • 6. Implementation Excellence
  • 7. Our Blue Ocean Strategy
Back to Top